Amgen income tops $2B in Q3
Thousand Oaks-based Amgen saw a slight decline in revenue for the third quarter of 2022, but a substantial increase in earnings helped the company beat analysts’ expectations and maintain its stock price. One of the largest biotechnology companies in the world, Amgen delivered net income of $2.1 billion, or $3.98 per share, in the third Read More →
Inogen shares drop after company reports net loss
Shares of Goleta-based Inogen dropped 7.8% on Nov. 2, after the company reported earnings for the third quarter of 2022 with growing revenue but a net loss higher than last year’s. Inogen, a maker of portable oxygen containers, reported a net loss of $9.5 million, or 42 cents per share, down from a net income Read More →
Community Memorial names new CEO
Community Memorial Health System has chosen a successor for Gary Wilde, who has announced his retirement as president and CEO of the Ventura County nonprofit hospital and clinic system. The new top executive will be Mick Zdeblick, the former CEO of Asante Rogue Regional Medical Center in Medford, Oregon. He will start at Community Memorial Read More →
Atara treatment nears European approval
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Marian hospital looks to build again in Santa Maria
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
New state Medicaid program arrives in tri-county region
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen shares up amid optimism over experimental weight-loss drug
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
